The IP results demonstrated that IFI16 and p300 interaction as well as IFI16 and H2B acetylation were inhibited in BRCA1 knockdown cells during KSHV de novo infection (Fig 10B). This evidence concerns the gene EP300 and Kaposi's sarcoma.